Embryologists are crucial in in vitro fertilization (IVF), managing embryo development and selection amidst increasing demand, but they face a shortage. Klaus Wiemer of Fairtility advocates for AI’s role in predicting embryo viability, notably through their FDA-approved tool, CHLOE, which analyzes millions of data points to identify embryos with the best chances for successful implantation. This innovation can significantly reduce the costs and time associated with genetic testing.
CHLOE continuously assesses embryo characteristics, aiming to minimize abnormalities without invasive biopsies. Wiemer envisions a future where every lab routinely employs such automatic assessments, allowing embryologists to focus more on research rather than administrative tasks. This shift not only enhances productivity but also enriches the scientific experience of embryologists, as they better understand embryo development and improve selection outcomes.
👉 Pročitaj original: MIT Technology Review – AI
